Human BCMA (CD269) Recombinant

//Human BCMA (CD269) Recombinant

Human BCMA (CD269) Recombinant


accession Q02223

Source Optimized DNA sequence encoding Human BCMA extracellular sp|Q02223|5-54 domain was expressed in Escherichia Coli.
Molecular weight Recombinant BCMA is a monomer protein consisting of 50 amino acid residue subunits,and migrates as an approximately 5kDa protein under non-reducing and reducing conditions in SDS-PAGE.
Purity >95%, as determined by SDS-PAGE and HPLC
Biological Activity The ED(50) was not determined.
Endotoxin Endotoxin content was assayed using a LAL gel clot method. Endotoxin level was found to be less than.1 ng/µg(1EU/µg).
Presentation Recombinant BCMA was lyophilized from a.2 μm filtered% acetonitrile,.1% TFA solutionpH.5.
Reconstitution A quick spin of the vial followed by reconstitution in distilled water to a concentration not less than.1 mg/mL. This solution can then be diluted into other buffers.
Storage The lyophilized protein is stable for at least years from date of receipt at -20° C. Upon reconstitution, this product can be stored in working aliquots at° -° C for one month, or at -20° C for six months, with a carrier protein without detectable loss of activity. Avoid repeated freeze/thaw cycles.
Usage This product is for research purposes only.It may not be used for therapeutics or diagnostic purposes.

Biological Process Immunity
Molecular function Receptor